Related Experiment Videos
[Systemic and biochemical manifestations of hepatoblastomas (author's transl)]
Klinische Padiatrie
|July 1, 1978
Insights
Hepatoblastoma, a rare liver cancer in children, was found in 1.8% of malignant solid tumors in boys. Systemic symptoms can signal this abdominal tumor, aiding early diagnosis and treatment.
Area of Science:
- Pediatric Oncology
- Hepatobiliary Cancers
Background:
- Malignant solid tumors in children are a significant concern in pediatric oncology.
- Hepatoblastoma represents a rare but critical diagnosis within this group.
Observation:
- A study at the University Children Hospital and Department of Pediatric Surgery in Graz reviewed 220 children with malignant solid tumors.
- Six cases (1.8%) of hepatoblastoma were identified among these patients.
Findings:
- All identified hepatoblastoma cases occurred in male patients.
- The study highlights that systemic manifestations can appear before the abdominal mass is detected.
Implications:
- Recognizing early systemic signs is crucial for the timely diagnosis of pediatric hepatoblastoma.
- These manifestations are important for both initial diagnosis and ongoing patient follow-up in pediatric cancer care.
Abstract:
Among 220 children with malignant solid tumors diagnosed at the University Children Hospital and Department of Pediatric Surgery in Graz six (1,8%) hepatoblastomas were found. All patients were boys. Systemic manifestations may precede the discovery of the abdominal mass and may be important for diagnosis and follow-up.